HistoSonics (histosonics.com) is a U.S.-based medical technology company specializing in the development of non-invasive therapeutic platforms that use advanced ultrasound technology to treat serious diseases such as cancer. Founded in 2009 and headquartered in Minnesota, the company operates within the medical device and healthcare innovation sector, focusing on transforming how tumors and diseased tissue are treated. At the core of HistoSonics innovation is its proprietary histotripsy technology, a novel form of focused ultrasound that uses high-intensity sound waves to mechanically destroy and liquefy targeted tissue at a sub-cellular level. Unlike traditional treatments such as surgery, radiation, or chemotherapy, histotripsy is non-invasive, non-thermal, and non-ionizing, meaning it does not require incisions, needles, or radiation exposure. The companys flagship product, the EdisonĀ® Histotripsy System, has received U.S. FDA clearance and is designed primarily for the treatment ofRead more
HistoSonics's Social Media
SIC Code 87,873NAICS Code 54,541Show more